L

Labiana Health SA
MAD:LAB

Watchlist Manager
Labiana Health SA
MAD:LAB
Watchlist
Price: 3.1 EUR 1.31% Market Closed
Market Cap: 22.4m EUR

Intrinsic Value

The intrinsic value of one LAB stock under the Base Case scenario is 16.8 EUR. Compared to the current market price of 3.1 EUR, Labiana Health SA is Undervalued by 82%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LAB Intrinsic Value
16.8 EUR
Undervaluation 82%
Intrinsic Value
Price
L
Worst Case
Base Case
Best Case

Valuation History
Labiana Health SA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
LAB
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for LAB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Labiana Health SA
MAD:LAB
ES
Pharmaceuticals
Market Cap
21.4m EUR
IPO
Jun 24, 2022
ES
Pharmaceuticals
Market Cap
21.4m EUR
IPO
Jun 24, 2022
Price
€false
EPS
€false
AI Assistant
AI Assistant
Ask me anything about Labiana Health SA
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Labiana Health SA

Balance Sheet Decomposition
Labiana Health SA

Current Assets 28.7m
Cash & Short-Term Investments 6.9m
Receivables 10.9m
Other Current Assets 10.9m
Non-Current Assets 23.3m
Long-Term Investments 2.1m
PP&E 12.7m
Intangibles 6m
Other Non-Current Assets 2.5m
Efficiency

Free Cash Flow Analysis
Labiana Health SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Labiana Health SA

Revenue
66.3m EUR
Cost of Revenue
-24.8m EUR
Gross Profit
41.4m EUR
Operating Expenses
-35.8m EUR
Operating Income
5.6m EUR
Other Expenses
-5.3m EUR
Net Income
253.5k EUR
Fundamental Scores

LAB Profitability Score
Profitability Due Diligence

Labiana Health SA's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 1-Year Revenue Growth
Positive ROE
Positive Operating Income
33/100
Profitability
Score

Labiana Health SA's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

LAB Solvency Score
Solvency Due Diligence

Labiana Health SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
45/100
Solvency
Score

Labiana Health SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LAB Price Targets Summary
Labiana Health SA

There are no price targets for LAB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Labiana Health SA
does not pay dividends
Shareholder Yield

Current shareholder yield for LAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one LAB stock?

The intrinsic value of one LAB stock under the Base Case scenario is 16.8 EUR.

Is LAB stock undervalued or overvalued?

Compared to the current market price of 3.1 EUR, Labiana Health SA is Undervalued by 82%.

Back to Top